The embargo on all abstracts accepted to the 2020 Gastrointestinal Cancers Symposium will lift at 5:00 p.m. ET on Tuesday, January 21, 2020.
Attend the Meeting in Person
Media registration for the 2020 Gastrointestinal Cancers Symposium is now open. At this time, you can visit ASCO's Media Headquarters to apply for media credentials*, register to attend an upcoming meeting, and access embargoed meeting information. For questions about how to navigate the site, please contact ASCO Media Registration.
*If you attended the 2019 ASCO Annual Meeting or covered the meeting remotely, you have already been credentialed by ASCO and will have access to the embargoed meeting information. You only have to register if you want to attend the Symposium in person in San Francisco.
Access Embargoed Information
Embargoed meeting information will be made available to credentialed media through ASCO's Media Headquarters. Once your media credentials are approved, you will receive email notifications when embargoed information has been posted.
- Young Adults With Colorectal Cancer in Low-Income and Low-Education Areas, or Urban Areas, Have Worse Overall Survival and a Higher Risk of Death
A retrospective analysis of 26,768 young adults age 40 and under found that those who live in areas with lower income (less than $38,000) and lower education (under 79% high school graduation rate), as well as those who live in urban areas, had worse outcomes and a higher risk of death. The results will be presented at the 2020 Gastrointestinal Cancers Symposium, taking place January 23-25 in San Francisco, California. Read more.
- Blood-Based Test Could Help Identify Hard-to-Detect Gastrointestinal Cancers
A blood-based screening test using cell-free DNA to identify methylation signals of hard-to-detect gastrointestinal (GI) cancers that could potentially help detect cancer at earlier stages will be presented 2020 Gastrointestinal Cancers Symposium, taking place January 23-25 in San Francisco, California. Read more.
- New Drug Combinations Maintain Quality of Life for Patients With Colorectal and Liver Cancers
Patient-reported outcomes from two large studies show that quality of life is maintained longer with newer drug combinations compared with standard of care for the treatment of patients with a specific type of colorectal cancer and unresectable hepatocellular carcinoma. The results will be presented at the 2020 Gastrointestinal Cancers Symposium, taking place January 23-25 in San Francisco, California. Read more.